Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$900M |
| 2 |
Cisco
CSCO
|
+$204M |
| 3 |
Amazon
AMZN
|
+$152M |
| 4 |
Johnson & Johnson
JNJ
|
+$150M |
| 5 |
Brookfield Infrastructure
BIPC
|
+$110M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$430M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$305M |
| 3 |
TWNK
Hostess Brands, Inc. Class A Common Stock
TWNK
|
+$299M |
| 4 |
Merck
MRK
|
+$291M |
| 5 |
TRTN
Triton International Limited
TRTN
|
+$282M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.11% |
| 2 | Financials | 17.15% |
| 3 | Industrials | 13.2% |
| 4 | Consumer Discretionary | 11.26% |
| 5 | Healthcare | 10.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NGM
3251
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $133K | ﹤0.01% |
154,456
-53,442
| -26% | -$46.9K |
|
3252
Comstock Holding Companies
CHCI
$151M
| $129K | ﹤0.01% |
28,804
| – | – |
|
3253
Fathom Holdings
FTHM
$26.3M
| $126K | ﹤0.01% |
35,208
| – | – |
|
|
SGMA
3254
DELISTED
Sigmatron International
SGMA
| $126K | ﹤0.01% |
42,054
| – | – |
|
3255
Forafric Global
AFRI
$282M
| $126K | ﹤0.01% |
+11,879
| New | +$131K |
|
3256
Weave Communications
WEAV
$522M
| $125K | ﹤0.01% |
10,866
-2,837
| -21% | -$25.1K |
|
|
TVRD
3257
Tvardi Therapeutics
TVRD
$19.7M
| $124K | ﹤0.01% |
4,648
-2,366
| -34% | -$98K |
|
3258
Milestone Pharmaceuticals
MIST
$143M
| $123K | ﹤0.01% |
73,704
-13,135
| -15% | -$35.7K |
|
3259
Immuneering
IMRX
$274M
| $123K | ﹤0.01% |
16,684
| – | – |
|
3260
Virgin Galactic
SPCE
$329M
| $121K | ﹤0.01% |
2,470
+1,778
| +257% | +$70.2K |
|
3261
Jerash Holdings
JRSH
$58.4M
| $120K | ﹤0.01% |
39,048
-2,214
| -5% | -$6.7K |
|
3262
Turkcell
TKC
$4.72B
| $119K | ﹤0.01% |
24,739
+829
| +3% | +$3.9K |
|
3263
MediaAlpha
MAX
$732M
| $115K | ﹤0.01% |
10,278
| – | – |
|
|
LNAI
3264
Lunai Bioworks
LNAI
$9.16M
| $115K | ﹤0.01% |
452
+187
| +71% | +$51.2K |
|
3265
Medallion Financial
MFIN
$233M
| $113K | ﹤0.01% |
11,451
| – | – |
|
3266
Marker Therapeutics
MRKR
$18.7M
| $112K | ﹤0.01% |
20,278
| – | – |
|
|
NOTV
3267
DELISTED
Inotiv
NOTV
| $111K | ﹤0.01% |
30,329
-22,227
| -42% | -$56.1K |
|
|
SOHO
3268
DELISTED
Sotherly Hotels
SOHO
| $111K | ﹤0.01% |
74,548
-26,092
| -26% | -$40.5K |
|
3269
Design Therapeutics
DSGN
$788M
| $111K | ﹤0.01% |
41,848
-12,267
| -23% | -$28.1K |
|
3270
Byrna Technologies
BYRN
$103M
| $109K | ﹤0.01% |
17,040
-4
| -0% | -$20 |
|
|
SY
3271
So-Young International
SY
$184M
| $109K | ﹤0.01% |
86,282
-3,046
| -3% | -$3.37K |
|
3272
Century Therapeutics
IPSC
$395M
| $108K | ﹤0.01% |
32,598
+4,572
| +16% | +$8.33K |
|
|
PMD
3273
DELISTED
Psychemedics Corporation
PMD
| $107K | ﹤0.01% |
36,117
-2,067
| -5% | -$5.51K |
|
3274
Sypris Solutions
SYPR
$44.2M
| $105K | ﹤0.01% |
52,032
-5,111
| -9% | -$9.88K |
|
|
TAIT
3275
DELISTED
Taitron Components
TAIT
| $104K | ﹤0.01% |
29,669
| – | – |
|
Similar funds
Dimensional Fund Advisors's Q4 2023 Portfolio in Review
As of Q4 2023, Dimensional Fund Advisors held 3,516 positions worth $342B, up 12% from $305B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Trading was light in Q4 2023: portfolio turnover was 4.3%. Dimensional Fund Advisors opened 49 new positions and exited 103, leaving the 3,516-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q4 2023 buy was Veralto: 961,231 shares worth $79.1M.
- Dimensional Fund Advisors added most to NVIDIA in Q4 2023, an estimated $900M increase.
- Dimensional Fund Advisors's biggest Q4 2023 reduction was Meta Platforms (Facebook), cutting an estimated $430M.
- Dimensional Fund Advisors fully exited Activision Blizzard in Q4 2023, selling an estimated $305M.
- Dimensional Fund Advisors's ten largest holdings make up 12% of its $342B portfolio in Q4 2023.
- Dimensional Fund Advisors opened 49 new positions and closed 103 in Q4 2023.
- Dimensional Fund Advisors's portfolio value rose 12% quarter-over-quarter to $342B.
Based on Dimensional Fund Advisors's 13F filing for Q4 2023, filed 7 Feb 2024.